Cellectis (CLLS) Cash from Operations (2015 - 2026)
Cellectis (CLLS) posted Cash from Operations of 15410000.0 for Q1 2026, down 48.75% on a QoQ basis from 10360000.0 in Q4 2025, and up 10.2% year-over-year from 13983902.7 in Q1 2025.
Cellectis (CLLS) has 12 years of Cash from Operations data on file, last reported at 15410000.0 in Q1 2026.
- In Q1 2026, Cash from Operations rose 10.2% year-over-year to 15410000.0; the TTM figure through Mar 2026 stood at 37651000.0 (down 229.19% YoY), while the FY2025 annual figure was 39401000.0, down 271.39% from the prior year.
- Cash from Operations retreated to 15410000.0 in Q1 2026, from 10360000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 52180000.0 in Q2 2024 and bottomed at 36612000.0 in Q1 2022.
- A 5-year average of 8257000.0 and a median of 15410000.0 in 2026 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations jumped 3654.1% — and 2025, when it tumbled 21942.55%.
- Year by year, Cash from Operations stood at 1220000.0 in 2022, then jumped by 3654.1% to 43360000.0 in 2023, then slumped by 100.11% to 47000.0 in 2024, then tumbled by 21942.55% to 10360000.0 in 2025, then tumbled by 48.75% to 15410000.0 in 2026.
- The last three Cash from Operations figures came in at 15410000.0 (Q1 2026), 10360000.0 (Q4 2025), and 1571000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | -15.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.41 Mn |
| Mar 31, 2026 | -15.41 Mn |
| Dec 31, 2025 | -10.36 Mn |
| Dec 31, 2025 | -10.36 Mn |
| Sep 30, 2025 | -1.57 Mn |
| Sep 30, 2025 | -1.57 Mn |
| Jun 30, 2025 | -10.31 Mn |
| Jun 30, 2025 | -10.31 Mn |
| Mar 31, 2025 | -17.16 Mn |
| Mar 31, 2025 | -17.16 Mn |
| Dec 31, 2024 | -47,000.00 |
| Dec 31, 2024 | -47,000.00 |
| Sep 30, 2024 | -5.83 Mn |
| Sep 30, 2024 | -5.83 Mn |
| Jun 30, 2024 | 52.18 Mn |
| Jun 30, 2024 | 52.18 Mn |
| Mar 31, 2024 | -23.32 Mn |
| Mar 31, 2024 | -23.32 Mn |
| Dec 31, 2023 | 43.36 Mn |
| Dec 31, 2023 | 43.36 Mn |
| Sep 30, 2023 | -17.09 Mn |
| Sep 30, 2023 | -17.09 Mn |
| Jun 30, 2023 | -19.04 Mn |
| Jun 30, 2023 | -19.04 Mn |
| Mar 31, 2023 | -28.33 Mn |
| Mar 31, 2023 | -28.33 Mn |
| Dec 31, 2022 | -1.22 Mn |
| Dec 31, 2022 | -1.22 Mn |
| Sep 30, 2022 | -26.04 Mn |
| Sep 30, 2022 | -26.04 Mn |
| Jun 30, 2022 | -23.57 Mn |
| Jun 30, 2022 | -23.57 Mn |
| Mar 31, 2022 | -36.61 Mn |
| Mar 31, 2022 | -36.61 Mn |
| Dec 31, 2021 | -21.08 Mn |
| Dec 31, 2021 | -21.08 Mn |
| Sep 30, 2021 | -30.43 Mn |
| Sep 30, 2021 | -30.43 Mn |
| Jun 30, 2021 | -12.13 Mn |
| Jun 30, 2021 | -12.13 Mn |
| Mar 31, 2021 | -40.93 Mn |
| Mar 31, 2021 | -40.93 Mn |
| Dec 31, 2020 | -33.89 Mn |
| Dec 31, 2020 | -33.89 Mn |
| Sep 30, 2020 | -25.61 Mn |
| Sep 30, 2020 | -25.61 Mn |
| Jun 30, 2020 | -22.22 Mn |
| Jun 30, 2020 | -22.22 Mn |
| Mar 31, 2020 | 1.46 Mn |
| Mar 31, 2020 | 1.46 Mn |
| Dec 31, 2019 | -7.31 Mn |
| Dec 31, 2019 | -7.31 Mn |
| Sep 30, 2019 | -22.65 Mn |
| Sep 30, 2019 | -22.65 Mn |
| Jun 30, 2019 | -21.22 Mn |
| Jun 30, 2019 | -21.22 Mn |
| Mar 31, 2019 | -22.40 Mn |
| Mar 31, 2019 | -22.40 Mn |
| Dec 31, 2018 | -20.60 Mn |
| Dec 31, 2018 | -20.60 Mn |
| Sep 30, 2018 | -15.01 Mn |
| Sep 30, 2018 | -15.01 Mn |
| Jun 30, 2018 | -12.54 Mn |
| Jun 30, 2018 | -12.54 Mn |
| Mar 31, 2018 | -19.98 Mn |
| Mar 31, 2018 | -19.98 Mn |
| Dec 31, 2017 | -9.51 Mn |
| Dec 31, 2017 | -9.51 Mn |
| Sep 30, 2017 | -15.49 Mn |
| Sep 30, 2017 | -15.49 Mn |
| Jun 30, 2017 | -17.40 Mn |
| Jun 30, 2017 | -17.40 Mn |
| Mar 31, 2017 | -16.28 Mn |
| Mar 31, 2017 | -16.28 Mn |
| Dec 31, 2016 | 1.66 Mn |
| Dec 31, 2016 | 1.66 Mn |
| Sep 30, 2016 | -1.91 Mn |
| Sep 30, 2016 | -1.91 Mn |
| Jun 30, 2016 | -10.74 Mn |
| Jun 30, 2016 | -10.74 Mn |
| Mar 31, 2016 | -21.61 Mn |
| Mar 31, 2016 | -21.61 Mn |
| Dec 31, 2015 | 27.64 Mn |
| Dec 31, 2015 | 27.64 Mn |
| Sep 30, 2015 | -5.11 Mn |
| Sep 30, 2015 | -5.11 Mn |
| Jun 30, 2015 | -17.87 Mn |
| Jun 30, 2015 | -17.87 Mn |
| Mar 31, 2015 | -1.38 Mn |
| Mar 31, 2015 | -1.38 Mn |